I. Alvarez-maya et al., In vivo gene transfer to dopamine neurons of rat substantia nigra via the high-affinity neurotensin receptor, MOL MED, 7(3), 2001, pp. 186-192
Citations number
39
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Background: Recently, we synthesized a nonviral gene vector capable of tran
sfecting cell lines taking advantage of neurotensin (NT) internalization. T
he vector is NT cross-linked with poly-L-lysine, to which a plasmid DNA was
bound to form a complex (NT-polyplex). Nigral dopamine neurons are able to
internalize NT, thus representing a target for gene transfer via NT-polypl
ex. This hypothesis was tested here using reporter genes encoding green flu
orescent protein or chloramphenicol acetyl transferase.
Materials and Methods. NT-polyplex was injected into the substantia nigra.
Double immunofluorescence labeling was used to reveal the cell type involve
d in the propidium iodide-labeled polyplex internalization and reporter gen
e expression.
Results. Polyplex internalization was observed within dopamine neurons but
not within glial cells, and was pre-vented by both hypertonic sucrose solut
ion and SR-48692, a selective nonpeptide antagonist of NT receptors. Report
er gene expression was observed in dopamine neurons from 48 hr up to 15 day
s after NT-polyplex injection, and was prevented by SR-48692. However, no e
xpression was seen when the NT-polyplex was injected into the ansiform lobu
le of the cerebellum, which contains low- but not high-affinity NT receptor
s. Neither internalization nor expression was observed in cultured glial ce
lls, despite the NT-polyplex binding to those cells that was prevented by l
evocabastine, a low-affinity NT receptor antagonist.
Conclusions. These results suggest that high-affinity NT receptors mediate
the uptake of NT-polyplex with the subsequent reporter gene expression in v
ivo. NT polyfection may be used to transfer genes of physiologic interest t
o nigrostriatal dopamine neurons, and to produce transgenic animal models o
f dopamine-related diseases.